Evidence map›Paper›PMID 28158290›Full record

ArticlePloS one2017

Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from Clostridium perfringens.

Julie M Grondin, Da Duan, Alyssa C Kirlin, Kento T Abe, Seth Chitayat, Holly L Spencer, Craig Spencer, Alisha Campigotto, Scott Houliston, Cheryl H Arrowsmith and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Structure of the Streptococcus pyogenes NADJournal of bacteriology · 2022
    Article
  4. Architecturally complexProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Prospecting for microbial α-The Journal of biological chemistry · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Julie M GrondinDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Da DuanDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Alyssa C KirlinDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Kento T AbeDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Seth ChitayatDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Holly L SpencerDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Craig SpencerDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Alisha CampigottoDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Scott HoulistonPrincess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Cheryl H ArrowsmithPrincess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
John S AllinghamDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Alisdair B BorastonDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Steven P SmithDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Queen's University · CAUniversity of Toronto · CAUniversity of Victoria · CAAgriculture and Agri-Food Canada · CA

Funding

Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
NIGMS NIH HHS P41 GM111244
6 · The paper itself

Abstract

Clostridium perfringens is a commensal member of the human gut microbiome and an opportunistic pathogen whose genome encodes a suite of putative large, multi-modular carbohydrate-active enzymes that appears to play a role in the interaction of the bacterium with mucin-based carbohydrates. Among the most complex of these is an enzyme that contains a presumed catalytic module belonging to glycoside hydrolase family 31 (GH31). This large enzyme, which based on its possession of a GH31 module is a predicted α-glucosidase, contains a variety of non-catalytic ancillary modules, including three CBM32 modules that to date have not been characterized. NMR-based experiments demonstrated a preference of each module for galacto-configured sugars, including the ability of all three CBM32s to recognize the common mucin monosaccharide GalNAc. X-ray crystal structures of the CpGH31 CBM32s, both in apo form and bound to GalNAc, revealed the finely-tuned molecular strategies employed by these sequentially variable CBM32s in coordinating a common ligand. The data highlight that sequence similarities to previously characterized CBMs alone are insufficient for identifying the molecular mechanism of ligand binding by individual CBMs. Furthermore, the overlapping ligand binding profiles of the three CBMs provide a fail-safe mechanism for the recognition of GalNAc among the dense eukaryotic carbohydrate networks of the colonic mucosa. These findings expand our understanding of ligand targeting by large, multi-modular carbohydrate-active enzymes, and offer unique insights into of the expanding ligand-binding preferences and binding site topologies observed in CBM32s.

Indexed as

CarbohydratesClostridium perfringensCrystallography, X-RayGlycoside HydrolasesGlycosidesProtein Structure, SecondaryCarbohydratesGlycoside HydrolasesGlycosides

Identifiers

PMID28158290
PMCPMC5291390
OpenAlexW2583455613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.